Clustering of extrasynaptic GABA(A) receptors modulates tonic inhibition in cultured hippocampal neurons.
Tonic inhibition plays a crucial role in regulating neuronal excitability because it sets the threshold for action potential generation and integrates excitatory signals. Tonic currents are known to be largely mediated by extrasynaptic gamma-aminobutyric acid type A (GABA(A)) receptors that are persistently activated by submicromolar concentrations of ambient GABA. We recently reported that, in cultured hippocampal neurons, the clustering of synaptic GABA(A) receptors significantly affects synaptic transmission. In this work, we demonstrated that the clustering of extrasynaptic GABA(A) receptors modulated tonic inhibition. Depolymerization of the cytoskeleton with nocodazole promoted the disassembly of extrasynaptic clusters of delta and gamma(2) subunit-containing GABA(A) receptors. This effect was associated with a reduction in the amplitude of tonic currents and diminished shunting inhibition. Moreover, diffuse GABA(A) receptors were less sensitive to the GAT-1 inhibitor NO-711 and to flurazepam. Quantitative analysis of GABA-evoked currents after prolonged exposure to submicromolar concentrations of GABA and model simulations suggest that clustering affects the gating properties of extrasynaptic GABA(A) receptors. In particular, a larger occupancy of the singly and doubly bound desensitized states can account for the modulation of tonic inhibition recorded after nocodazole treatment. Moreover, comparison of tonic currents recorded during spontaneous activity and those elicited by exogenously applied low agonist concentrations allows estimation of the concentration of ambient GABA. In conclusion, receptor clustering appears to be an additional regulating factor for tonic inhibition.
Neuroscience Programme, International School for Advanced Studies, Via Beirut 2-4, 34014 Trieste, Italy.
Enrica Maria
EM
Petrini
Ivan
I
Marchionni
Paola
P
Zacchi
Werner
W
Sieghart
Enrico
E
Cherubini
D000818:Animals; D002478:Cells, Cultured; D005479:Flurazepam / Q000494:pharmacology; D006624:Hippocampus / Q000502:physiology*; D009433:Neural Inhibition; D009557:Nipecotic Acids / Q000494:pharmacology; D015739:Nocodazole / Q000494:pharmacology; D010091:Oximes / Q000494:pharmacology; D021122:Protein Subunits; D051381:Rats; D011963:Receptors, GABA-A / Q000737:chemistry / Q000502:physiology*; D013779:Tetrodotoxin / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D009557:Nipecotic Acids; D010091:Oximes; D021122:Protein Subunits; D011963:Receptors, GABA-A; C078793:NNC 711; D013779:Tetrodotoxin; D005680:gamma-Aminobutyric Acid; D005479:Flurazepam; D015739:Nocodazole